Unilever and Genomatica jointly invest US$120M, forming venture to create cleansing ingredients made with alternatives to palm oil, fossil fuel; initiative aims to offer plant-based ingredient for applications including cleaning, personal care products

Sample article from our Tissue & Hygiene

LONDON and SAN DIEGO , June 16, 2022 (press release) –

 

  • Using Geno’s cutting-edge biotechnology, the venture aims to commercialise and scale plant-based alternatives to feedstocks like palm oil, or fossil fuels, to make key ingredients used in everyday cleaning and personal care products.
  • Unilever’s investment, which is the first to support the venture, also marks the company’s largest collaboration in biotechnology alternatives to palm oil to date.
  • The venture is poised to offer a highly effective and sustainable alternative that can be offered to the combined $625b1 home and personal care markets.

Today Unilever and Genomatica (Geno), a leader in biotech and sustainability, have launched a venture to scale and commercialise alternatives to palm oil and fossil fuel-derived cleansing ingredients. These are integral to the formulations of thousands of everyday cleaning and personal care products. With growing demand for sustainably-sourced palm oil, this venture aims to deliver additional responsibly sourced palm oil alternatives to the market.

A woman in a white lab coat working at one of Geno’s biotech labs
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology. The innovation is particularly relevant to cleaning and personal care products that require ingredients to lather and lift dirt. But at present, there are few viable alternatives to palm and fossil sources that can be produced at scale in order to make those ingredients.

As such, the venture offers the opportunity to tap into the combined $625b home and personal care markets. For Unilever, one of the world’s biggest soap and detergent manufacturers, this is the largest investment in biotechnology alternatives to palm oil to date.

Companies like Unilever, whose products are used globally by 3.4b people each day, are increasingly partnering with biotechnology innovators like Geno to explore, develop, and manufacture new versions of traditionally-sourced ingredients. While palm oil will remain an important feedstock to Unilever, these alternative ingredients can play a growing role in diversifying supply chains to drive optionality, sustainability, cost efficiencies and transparency.

Geno will deploy its proven biotechnology platform and is already starting to scale the process for its advanced technology to produce the ingredients. Initial estimates have shown that companies could reduce the carbon footprint of palm-derived ingredients by up to 50% with this technology-driven, plant-based alternative.

Unilever’s Chief R&D Officer Richard Slater, said:

“Biotechnology has the potential to revolutionise the sourcing of our cleansing ingredients and ensure Unilever is a future-fit business – for consumers, shareholders and the planet we all share. This new venture will sit at the intersection of science and sustainability, meaning we can continue to grow our business without relying only on palm oil or fossil fuel derivatives, while also making our supply chains more resilient from having access to ingredient alternatives.

“We will be marrying science and nature to make sure there is no tradeoff for our consumers between the efficacy and sustainability of their products. We are building this innovative new venture to have the scale to drive real impact and change in our industry, helping to reinvent the chemistry of home and personal care products for the 21st Century.”

Christophe Schilling, Geno CEO said:

“Geno’s collaboration with Unilever builds upon its strong track record of partnering with market leaders who are committed to accelerating the commercialisation of sustainable materials in their industries – from clothing to now cleaning ingredients. We’ve developed our technology in response to our planet’s urgent climate crisis and we’ve proven that biotechnology can replace traditional production methods to produce ingredients with bio-based sources that deliver both high-performance and sustainability, at scale.

“Our technology enables pathways for alternative sourcing of materials whose supply chains often have limited social and environmental transparency, by offering more resilient supply chains that are transparent, traceable and responsibly-sourced, as demanded by consumers. Beyond creating new transparent and responsibly sourced-supply chains and alternatively-sourced materials, our Geno technology also represents the potential to reduce greenhouse gas emissions by 100 million tons in upcoming years.”

1 Source: Euromonitor

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.